SVA
NASDAQ · Biotechnology
Sinovac Biotech Ltd
$6.47
+0.00 (+0.00%)
Open$6.47
Previous Close$6.47
Day High$6.47
Day Low$6.47
52W High$6.47
52W Low$6.47
Volume—
Avg Volume0
Market Cap639.90M
P/E Ratio—
EPS$-1.25
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | |
|---|---|---|
| Revenue | 445.10M | 464.96M |
| Net Income | -99,209,845 | -93,271,555 |
| Profit Margin | -22.3% | -21.2% |
| EBITDA | -94,749,309 | -94,026,787 |
| Free Cash Flow | — | — |
| Rev Growth | -4.3% | -4.3% |
| Debt/Equity | 0.03 | 0.03 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $254.39 | +4.21% | 121.5 | 441.54B |
| AMGN | Amgen Inc | $371.58 | +3.70% | 25.2 | 196.23B |
| GILD | Gilead Sciences Inc | $136.30 | +3.49% | 17.5 | 161.65B |
| VRTX | Vertex Pharmaceuticals Inc | $486.03 | +1.88% | 28.6 | 123.92B |
| REGN | Regeneron Pharmaceuticals | $678.94 | +2.18% | 15.8 | 69.75B |
| ALNY | Alnylam Pharmaceuticals Inc | $283.15 | +1.44% | 72.5 | 41.83B |